2014 VAM: 4813 Stepping Down Asthma Medications: Benefits and Risks
Q & A Workshop: 4813 Stepping Down Asthma Medications: Benefits and Risks
AMA PRA Category 1 CreditsTM: 1.25
Upon completion of this session, participants should be able to:
- Identify asthma patients who may be good candidates for stepping down their asthma medication.
- Describe the risks associated with stepping down asthma medication with the best currently available evidence.
- Compare and contrast different types of step down strategies.
Credit must be claimed by May 31, 2016. Any credit request on or after June 1, 2016 will be subject to an administrative fee.
- 1.25 AttendanceAttendance credit.
- 1.50 CECE credit.
- 1.25 CMECME credit.